Madrigal Pharmaceuticals, Inc. (MDGL)
USD 292.76
(-4.35%)
USD 292.76
(-4.35%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 527 Thousand | 467 Thousand | 405 Thousand | 471 Thousand | 112 Thousand | 96 Thousand |
| Gross Profit | -527 Thousand | -467 Thousand | -405 Thousand | -471 Thousand | -112 Thousand | -96 Thousand |
| Operating Expenses | 380.49 Million | 293.57 Million | 242.48 Million | 206.67 Million | 94.97 Million | 40.68 Million |
| Selling, General and Administrative Expenses | 108.14 Million | 48.13 Million | 37.31 Million | 21.86 Million | 22.64 Million | 15.29 Million |
| Research and Development Expenses | 272.35 Million | 245.44 Million | 205.16 Million | 184.8 Million | 72.32 Million | 25.38 Million |
| Other Expenses | - | - | 273 Thousand | 100 Thousand | - | 200 Thousand |
| Cost and Expenses | 380.49 Million | 293.57 Million | 242.48 Million | 206.67 Million | 94.97 Million | 40.68 Million |
| Operating Income | -380.49 Million | -293.57 Million | -242.48 Million | -206.67 Million | -94.97 Million | -40.68 Million |
| Interest Expense | 12.71 Million | 3.96 Million | - | - | 11.02 Million | 7.67 Million |
| Income Tax Expense | - | 3.96 Million | -768 Thousand | -4.8 Million | -11.13 Million | 7.87 Million |
| Earnings before Tax | -373.63 Million | -295.35 Million | -241.84 Million | -202.24 Million | -83.94 Million | -32.81 Million |
| Net Income | -373.63 Million | -299.31 Million | -241.07 Million | -197.44 Million | -72.81 Million | -32.81 Million |
| Earnings Per Share Basic | -19.99 | -17.47 | -14.58 | -12.78 | -4.73 | -2.22 |
| Earnings Per Share Diluted | -19.99 | -17.47 | -14.58 | -12.78 | -4.73 | -2.22 |
| Weighted Average Shares Outstanding | 18.68 Million | 17.13 Million | 16.53 Million | 15.44 Million | 15.39 Million | 14.79 Million |
| Weighted Average Shares Outstanding (Diluted) | 18.68 Million | 17.13 Million | 16.53 Million | 15.44 Million | 15.39 Million | 14.79 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -379.96 Million | -293.1 Million | -242.07 Million | -206.2 Million | -94.86 Million | -40.58 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 62.17 Million | 14.63 Million | - | - | 770 Thousand | - |
| Cost of Revenue | 2.15 Million | 903 Thousand | 168 Thousand | 527 Thousand | 142 Thousand | 135 Thousand |
| Gross Profit | 60.02 Million | 13.73 Million | -168 Thousand | -527 Thousand | 628 Thousand | -135 Thousand |
| Operating Expenses | 176.32 Million | 176.27 Million | 151.86 Million | 379.96 Million | 117.03 Million | 98.53 Million |
| Selling, General and Administrative Expenses | 107.58 Million | 105.44 Million | 80.8 Million | - | 46.53 Million | 27.58 Million |
| Research and Development Expenses | 68.74 Million | 70.82 Million | 71.06 Million | - | 70.49 Million | 70.95 Million |
| Other Expenses | 298 Thousand | - | - | - | - | - |
| Cost and Expenses | 178.47 Million | 177.17 Million | 152.03 Million | 380.49 Million | 117.17 Million | 98.53 Million |
| Operating Income | -116.3 Million | -162.53 Million | -152.03 Million | -380.49 Million | -117.17 Million | -98.53 Million |
| Interest Expense | -3.67 Million | 3.65 Million | 3.83 Million | 12.71 Million | 3.97 Million | -3.5 Million |
| Income Tax Expense | -298 Thousand | - | - | - | 98.18 Thousand | -135 Thousand |
| Earnings before Tax | -106.96 Million | -151.97 Million | -147.54 Million | -373.63 Million | -112.19 Million | -98.74 Million |
| Net Income | -106.96 Million | -151.97 Million | -147.54 Million | -373.63 Million | -112.19 Million | -98.74 Million |
| Earnings Per Share Basic | -4.92 | -7.10 | -7.38 | - | -5.68 | -5.34 |
| Earnings Per Share Diluted | -4.92 | -7.10 | -7.38 | - | -5.68 | -5.34 |
| Weighted Average Shares Outstanding | 21.74 Million | 21.4 Million | 20 Million | 18.68 Million | 19.76 Million | 18.47 Million |
| Weighted Average Shares Outstanding (Diluted) | 21.74 Million | 21.4 Million | 20 Million | 18.68 Million | 19.76 Million | 18.47 Million |
| Gross Margin | 0.97 | 0.94 | - | - | 0.82 | - |
| EBIT Margin | -1.87 | -11.09 | - | - | -151.99 | - |
| Profit Margin | -1.72 | -10.38 | - | - | -145.71 | - |
| EBITDA | -116.3 Million | -162.27 Million | -151.86 Million | - | -117.03 Million | -98.53 Million |
| Earnings Before Tax Margin | -1.87 | -11.10 | - | - | -152.18 | - |
EXAE
ENX
ARKR
DHARMAJ
000926
0IZM